References
- FinnRSCurrent and future treatment strategies for patients with advanced hepatocellular carcinoma: role of mTOR inhibitionLiver Cancer201213–424725624159589
- ZhouYLiangCXueFSalinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activationOncotarget2015612103501036525871400
- FornerAGilabertMBruixJRaoulJLTreatment of intermediate-stage hepatocellular carcinomaNat Rev Clin Oncol201411952553525091611
- WuQYangZNileYShiYFanDMulti-drug resistance in cancer chemotherapeutics: mechanisms and lab approachesCancer Lett2014347215916624657660
- PirkerRPereiraJRvon PawelJEGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX studyLancet Oncol2012131334222056021
- ZhuAXStuartKBlaszkowskyLSPhase 2 study of cetuximab in patients with advanced hepatocellular carcinomaCancer2007110358158917583545
- SanoffHKBernardSGoldbergRMPhase II study of capecitabine, oxaliplatin, and cetuximab for advanced hepatocellular carcinomaGastrointest Cancer Res201143788322043322
- ChenWHuQDXiaXFRapamycin enhances cetuximab cytotoxicity by inhibiting mTOR-mediated drug resistance in mesenchymal hepatoma cellsCancer Biol Ther201415899299924800850
- HuangSHeRRongMDangYChenGSynergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cellsBiomed Res Int2014201438412124895573
- AugelloCVairaVCarusoLMicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinomaLiver Int201232577278222429613
- SatoFHatanoEKitamuraKMicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan CriteriaPLoS One201161e1643521298008
- LiuQLvGDQinXRole of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinomaMol Biol Rep20123921239124621598109
- WagnerSNgezahayoAMurua EscobarHNolteIRole of miRNA let-7 and its major targets in prostate cancerBiomed Res Int2014201437632625276782
- WongTSManOYTsangCMMicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expressionJ Cancer Res Clin Oncol2011137341542220440510
- GuanHZhangPLiuCCharacterization and functional analysis of the human microRNA let-7a2 promoter in lung cancer A549 cell linesMol Biol Rep20113885327533421365266
- LiZGuoYZhouLAssociation of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinomaMol Carcinog201554985385824729511
- RoushSSlackFJThe let-7 family of microRNAsTrends Cell Biol2008181050551618774294
- BruecknerBStresemannCKunerRThe human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic functionCancer Res20076741419142317308078
- LuLKatsarosDde la LongraisIASochircaOYuHHypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosisCancer Res20076721101171012217974952
- EzzoukhryZLouandreCTrecherelEEGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenibInt J Cancer2012131122961296922514082
- UngNPutoczkiTLStylliSSAnti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activityCancer Biol Ther201415562363224556630
- ChenWShenXXiaXNSC 74859-mediated inhibition of STAT3 enhances the anti-proliferative activity of cetuximab in hepatocellular carcinomaLiver Int2012321707722098470
- WheelerSESuzukiSThomasSMEpidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activationOncogene201029375135514520622897
- IidaMBrandTMStarrMMOvercoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapyMol Cancer20141324225344208